Physician

Liangyong Jiang

According to 2025 Medicare claims, Liangyong Jiang (NPI: 1912291212) practices rheumatology in the Greenville, NC market, with the plurality of this provider's patient population coming from Pitt, NC. This provider's primary affiliated billing organization is PHYSICIANS EAST, P.A. (NPI: 1598761967; TIN: 561968491) and primary practice location at 27834-5704. Jiang is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Jiang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,308 traditional Medicare patients, billed 41,058 HCPCS/CPT codes, and received $629,034 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,471 prescription claims across 860 beneficiaries totaling $5,386,632 in drug costs, led by Enbrel Mini (Etanercept). Open Payments data shows 41 records totaling $560. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $491,556 and ending at $629,034. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $920,113 to $5,386,632. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,285	32,061	$491,556
2016	1,369	27,507	$416,322
2017	1,193	16,132	$350,858
2018	1,227	17,307	$560,987
2019	1,318	26,813	$503,428
2020	1,199	23,005	$342,582
2021	1,303	24,659	$500,898
2022	1,163	19,579	$494,030
2023	1,352	34,863	$677,033
2024	1,308	41,058	$629,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	523	3,876	$920,113
2016	490	4,096	$1,165,810
2017	510	4,042	$1,599,096
2018	530	3,962	$2,294,016
2019	559	3,928	$2,168,345
2020	639	3,961	$2,581,181
2021	722	5,224	$3,461,902
2022	693	4,918	$3,749,435
2023	809	5,951	$5,471,595
2024	860	6,471	$5,386,632

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	350	615	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	264	342	$64
77080	Dxa bone density measurement of hip, pelvis, spine	250	250	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	327	502	$12
36415	Insertion of needle into vein for collection of blood sample	273	508	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Mini	Etanercept	106	2,968	$803,868
Rinvoq	Upadacitinib	111	3,330	$715,426
Enbrel Sureclick	Etanercept	93	2,620	$675,850
Xeljanz Xr	Tofacitinib Citrate	105	3,150	$636,282
Humira Pen	Adalimumab	90	2,576	$620,311

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$560	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Liangyong Jiang?

Tedicare shows public-source Medicare data for Liangyong Jiang (NPI 1912291212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Liangyong Jiang have ACO affiliation data?

Liangyong Jiang is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Liangyong Jiang?

Liangyong Jiang is linked to PHYSICIANS EAST, P.A. (billing NPI 1598761967) in the available physician profile data.

Does Liangyong Jiang have Open Payments data?

Liangyong Jiang has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.